Asia Pacific End Stage Renal Disease Market Size & Outlook

The end stage renal disease market in Asia Pacific is expected to reach a projected revenue of US$ 99,670.3 million by 2030. A compound annual growth rate of 13.2% is expected of Asia Pacific end stage renal disease market from 2024 to 2030.